{"id":"W1996349490","doi":"10.1002/hep.26274","title":"Propel: A Randomized Trial of Mericitabine Plus Peginterferon Alpha-2a/Ribavirin Therapy in Treatment-NaïVe HCV Genotype 1/4 Patients","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Ribavirin; Medicine; Genotype; Randomized controlled trial; Internal medicine; Alpha (finance); Gastroenterology; Virology; Hepatitis C virus; Surgery; Biology; Virus; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001370684,0.001733565,0.002378404,0.0004371202,0.0003600672,0.001211228,0.001034276,0.001474723,0.01029076],"category_scores_gemma":[0.001600858,0.0007101064,0.001267116,0.0003607592,0.00107445,0.001140051,0.0005861879,0.002551712,0.0009762908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005604211,"about_ca_system_score_gemma":0.001111018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005691466,"about_ca_topic_score_gemma":0.00147167,"domain_scores_codex":[0.9995201,0.0003025785,0.00002655176,0.00005714253,0.00002556357,0.00006804391],"domain_scores_gemma":[0.9991624,0.0002199783,0.0001841444,0.00004527611,0.00004139408,0.0003467842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9889749,0.001838881,0.0002010005,0.000384451,0.0003081372,0.00003068087,0.00001484173,0.0001301428,0.0009732049,0.00005417315,0.0003281226,0.006761385],"study_design_scores_gemma":[0.9763056,0.02265835,0.0003544719,0.00001776765,0.0001357176,0.00001529315,0.000008758245,0.0001134506,0.0001096783,0.00005033379,0.0002259253,0.000004711746],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850676,0.005747064,0.0004456521,0.001193723,0.00104561,0.003009003,0.001027619,0.0001642507,0.002299541],"genre_scores_gemma":[0.9813203,0.003487924,0.001590639,0.001690384,0.0009181172,0.004278146,0.001430307,0.00002405177,0.005260255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01029076,"threshold_uncertainty_score":0.03442603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03851315673015657,"score_gpt":0.3267807605196495,"score_spread":0.2882676037894929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}